Selank

What Is Selank? Anxiety & Brain Function Peptide

Selank is a synthetic heptapeptide analog of tuftsin, an endogenous immunomodulatory peptide, with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and has been studied primarily for anxiety-related and nootropic applications. Selank is approved in Russia for the treatment of generalized anxiety disorder and as a nootropic, making it one of the few peptides in this category with a domestic regulatory approval. Outside Russia, it should generally be framed as a research compound rather than an approved therapeutic drug.

Selank sits firmly within the brain, cognitive, and nootropic peptide category because it is studied for anxiety modulation, stress response, cognitive performance, and neuroimmune signaling. As a brain peptide, Selank is researched for its interactions with central nervous system pathways involved in mood, cognition, and stress adaptation. It is available primarily as a nasal spray, the most studied and clinically discussed route, with subcutaneous injectable preparations also used in clinical practice.

What Does Selank Do? Mechanism of Action

Selank is studied as a multi-pathway nootropic and anxiolytic peptide. Its demonstrated and proposed mechanisms include the following:

• Enkephalinase inhibition: Selank demonstrably inhibits enkephalin-degrading enzymes with an IC₅₀ of 15 μM, making it more potent than bacitracin or puromycin. This preserves endogenous enkephalin levels involved in mood regulation, stress response, and anxiolytic signaling.
• GABAergic modulation: Selank acts as a positive allosteric modulator of GABA-A receptors with subtype-selective, concentration-dependent activity. Volkova et al. reported gene expression changes in neurotransmission pathways, while Filatova et al. observed effects on GABA-related receptor interactions in cellular models. This differs from benzodiazepines in that Selank’s binding sites appear distinct (though potentially partially overlapping), and joint action is not cumulative with benzodiazepines.
• Monoaminergic modulation: Selank influences monoamine neurotransmitter concentrations and induces serotonin metabolism, with relevance to mood, motivation, and cognitive clarity.
• BDNF upregulation: Selank rapidly elevates BDNF mRNA and protein expression in the hippocampus of rats in a dose-dependent manner, supporting research interest in neuroplasticity and cognitive enhancement.
• Neuroimmune signaling: As a tuftsin analog, Selank has been studied for its potential to suppress IL-6 gene expression in patients with anxiety disorders (not healthy controls), which is relevant to neuroinflammation and stress-related immune dysregulation.

Together, these pathways support research interest in Selank for anxiety, brain function, stress response, and neuroimmune signaling.

Selank Peptide Benefits: Cognitive Enhancement & Anxiety

Selank peptide benefits should be presented by evidence tier. It has a Russian clinical-use history and preclinical support, but the evidence base is not equivalent to that of large independently replicated Western Phase 3 trials.

• Anxiety and brain function: Selank has been evaluated in Russian clinical research for generalized anxiety disorder and neurasthenia. Zozulia et al. studied 62 patients comparing Selank with medazepam, demonstrating comparable anxiolytic efficacy alongside antiasthenic and psychostimulant effects not typically seen with conventional anxiolytics.
• Cognitive enhancement: Selank has been studied for effects on attention and memory consolidation, particularly during the consolidation phase of memory, with cognitive outcomes more clearly associated with repeated administration or structured protocols. Claims should remain evidence-qualified and should not be positioned as FDA-validated cognitive enhancement.
• Benzodiazepine differentiation: A key differentiator in the available literature is that Selank’s anxiolytic profile is described without the same sedation, muscle relaxation, tolerance development, or physical dependence concerns associated with conventional benzodiazepines. Kasian et al. studied Selank alongside diazepam in an animal stress model, showing anxiolytic effects in preclinical conditions.
• Nootropic stack context: Selank is sometimes positioned within broader nootropic or anti-aging protocols, including multi-peptide stacks. These applications are typically practitioner-reported or extrapolated and should not be presented as validated therapeutic outcomes.

Rapid effectiveness has been documented in clinical studies, with significant individual variability — some patients respond rapidly, while others require extended treatment. Cognitive effects on memory consolidation appear to require repeated administration or structured protocols, particularly during memory consolidation.

Selank Nasal Spray: Dosage & Administration

Selank nasal spray is the most commonly discussed route, with intranasal administration studied in Russian clinical and practitioner protocols for central nervous system exposure. Absorption can vary depending on formulation, technique, and product handling.

• Nasal spray dosage: Some protocols reference 250–1,000 mcg intranasally one to two times daily, depending on the indication and individual response.
• Injectable dosage: Subcutaneous preparations are also referenced in practitioner settings, though this route is less established than intranasal use. Outside Russia, all dosing should be framed as practitioner-reported or research-extrapolated rather than approved prescribing guidance.
• Selank withdrawal: Available literature does not describe a benzodiazepine-like physical dependence or withdrawal syndrome, which is one of Selank’s key differentiators from conventional anxiolytics. However, the absence of documented withdrawal does not replace the need for long-term safety monitoring.
• Storage: Refrigerate at 2–8°C, protect from light, and follow product-specific instructions for post-opening shelf life.

Clinical trials of Selank have documented sustained tolerability over extended periods, spanning months to years, without serious safety concerns or the development of dependence liability.

Selank Side Effects & Safety

• Intranasal use: Nasal irritation, transient discomfort, mild headache, or sore throat.
• Injectable use: Standard injection-site reactions such as redness, tenderness, or swelling.

It’s also important to consider what Selank is not typically associated with in the available literature: sedation, respiratory depression, muscle relaxation, tolerance development, or benzodiazepine-like physical dependence. This profile is a key reason Selank is discussed as an anxiety and brain function peptide rather than a conventional sedative anxiolytic.

Drug interaction data remain limited. Practitioners should use caution in patients taking benzodiazepines, antidepressants, antipsychotics, stimulants, or other CNS-active agents, as Selank may interact with neurochemical systems related to GABA, serotonin, dopamine, and endogenous peptides.

The absence of major documented interactions should not be interpreted as proof of universal compatibility. For US, EU, and Australian audiences, Selank should be treated as investigational unless local regulatory status indicates otherwise.

Selank vs Semax, DSIP, Oxytocin & Epithalon

Selank is most appropriately discussed when the research question centers on anxiety, stress resilience, cognitive function, and non-sedating anxiolytic mechanisms. Understanding how it compares with related peptides helps clarify its distinct positioning.

Semax

Selank and Semax are both Russian-developed nootropic peptides, but they are not interchangeable. Practitioners who perform research on Semax are evaluating a compound more closely associated with BDNF-linked neuroplasticity, ACTH-like mechanisms, alertness, and attention.

Selank’s primary differentiation is its anxiolytic and stress-modulating profile. Selank is more calming and relevant when anxiety and brain function are the primary research focus, while Semax is more stimulating and better suited to cognitive performance and neuroprotective models.

DSIP

Selank has been studied for enkephalinase inhibition, GABAergic anxiolysis, and modulation of waking cognitive anxiety. Practitioners who buy DSIP for sleep and circadian protocol research are targeting a distinct set of outcomes, as DSIP is more closely associated with sleep architecture, stress-axis modulation, and research on sleep-related peptides.

Selank is better aligned with daytime anxiety and cognitive clarity, while DSIP is more relevant when sleep quality, circadian regulation, or nocturnal stress physiology is the central research question.

Oxytocin

Selank and Oxytocin can both appear in discussions of stress-related peptides, but they act through entirely different systems. Practitioners who buy Oxytocin for social bonding or reproductive physiology research are working with a compound that acts through oxytocin receptors involved in bonding, social behavior, and stress responses. Selank acts through GABAergic, enkephalinergic, monoaminergic, and neuroimmune pathways and is more relevant to research on cognitive anxiety and stress resilience than to social or relational stress contexts.

Epithalon

Selank is generally discussed for shorter-term anxiety modulation, cognitive clarity, and brain function. Practitioners who buy Epithalon for longevity and cellular aging research are working with a compound positioned around circadian regulation, pineal biology, and telomere-related mechanisms. Selank is more relevant to acute or protocol-based nootropic and anxiety research, while Epithalon is more clearly associated with long-term cellular aging and circadian protocols.

Doctor Medica’s staff can provide additional context on these comparisons and can guide practitioners on sourcing from qualified suppliers.

Legal Status of Selank

As of June 2026, Selank’s regulatory status varies significantly by jurisdiction:

• Russia: Approved as a prescription medicine for generalized anxiety disorder and as a nootropic. This represents the most established regulatory status for any compound in this brief, but the evidence base is largely Russian or Eastern European and should be contextualized accordingly.
• United States: Not FDA-approved for any indication. Practitioners should consult the current FDA guidance directly on the 503A and 503B compounding frameworks before discussing any compounded formulation.
• Australia: Not TGA-approved for therapeutic use. Practitioners should verify the current TGA classification and the availability of compounding before any patient-facing discussion.
• WADA: Selank is not explicitly listed in the 2026 WADA Prohibited List; athletes should verify its current status independently, as peptide hormones fall under Class S2 and the list is updated annually. Lack of explicit naming does not guarantee exclusion from the broader class.

Professionals evaluating how to buy Selank wholesale should not treat catalog availability as clinical authorization. Any sourcing review should include identity testing, certificate of analysis, sterility controls, formulation route, storage conditions, intended-use language, and jurisdiction-specific restrictions. Wholesale pricing should remain secondary to regulatory alignment, documentation quality, and safety controls.

Where Can Practitioners Buy Selank Online?

Practitioners who choose to buy Selank online should confirm that any supplier serves qualified professionals only and provides documentation supporting a compliant research procurement decision. When evaluating how to purchase Selank from a verified source, practitioners should look for suppliers that provide a certificate of analysis, LOT number traceability, and clear purity documentation for each batch. These are minimum requirements for research-grade procurement and are not optional in a compliant sourcing workflow.

Practitioners who want to purchase Selank for licensed research protocols can contact Doctor Medica’s staff for guidance on identifying qualified suppliers and obtaining the supporting documentation needed to make informed sourcing decisions. Doctor Medica connects licensed professionals with research-grade suppliers and does not substitute for jurisdiction-specific regulatory review.

FAQs

1. What is Selank?

Selank is a synthetic heptapeptide analog of tuftsin developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is studied as a brain, cognitive, and nootropic peptide with anxiolytic, neuroimmune, and cognitive-function applications. Outside Russia, it should generally be framed as a research compound.

2. What does Selank do?

Selank demonstrably inhibits enkephalin-degrading enzymes, acts as a positive allosteric modulator of GABA-A receptors, influences monoamine neurotransmitter concentrations, and elevates BDNF expression in the hippocampus. These mechanisms support its anxiolytic and nootropic research profile. Evidence includes Russian clinical studies, animal models, and cellular research.

3. Does Selank work immediately?

Rapid effectiveness has been documented in clinical studies with significant individual variability. Some patients show a rapid response while others require extended treatment. Cognitive effects on memory consolidation appear to require repeated administration or structured protocols. Both timelines should be described as clinical findings with individual variation rather than universal guarantees.

4. Is Selank safe?

Selank is generally described as well-tolerated in Russian clinical and preclinical literature, with sustained tolerability documented over extended periods without serious safety concerns or dependence liability. Reported side effects are usually mild, including nasal irritation, headache, or transient discomfort. Practitioners treating non-Russian audiences should frame Selank as investigational pending local regulatory review.

5. What is the Selank dosage?

Some protocols reference 250–1,000 mcg intranasally one to two times daily, depending on indication and individual response. Subcutaneous preparations are also used in clinical practice but are less established than the intranasal route. Outside Russia, all dosing should be framed as research-extrapolated rather than approved prescribing guidance.

6. Does Selank cause withdrawal?

Selank is not associated in the available literature with benzodiazepine-like physical dependence or withdrawal. This is one of its key differentiators from conventional sedative anxiolytics. Clinical trial data spanning extended periods have not documented dependence liability, though long-term monitoring outside Russian clinical contexts remains advisable.

7. How does Selank compare to Semax?

Selank and Semax are both Russian-developed nootropic peptides, but they serve different research profiles. Selank is more calming and anxiolytic, while Semax is generally positioned as more stimulating and cognitive-performance-oriented. Selank is better suited to anxiety and stress modulation research, while Semax is more often discussed for attention, alertness, and neuroprotection.

References

1. Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016;7:31. Published 2016 Feb 18. doi:10.3389/fphar.2016.00031
2. Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein Pept Lett. 2018;25(10):914-923. doi:10.2174/0929866525666180925144642
3. Zozulya AA, Neznamov GG, Syunyakov TS, et al. Efficacy and mechanisms of action of the new peptide anxiolytic Selank in the therapy of generalized anxiety disorder and neurasthenia: an experimental and clinical study. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.
4. Kasian A, Kolomin T, Andreeva L, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017;2017:5091027. doi:10.1155/2017/5091027

For licensed medical professionals only. This content is for informational purposes only and does not constitute medical advice.